Prostate cancer, version 2.2014.

Published

Journal Article

Prostate cancer has surpassed lung cancer as the most common cancer in men in the United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer based on clinical evidence and expert consensus. NCCN Panel guidance on treatment decisions for patients with localized disease is represented in this version. Significant updates for early disease include distinction between active surveillance and observation, a new section on principles of imaging, and revisions to radiation recommendations. The full version of these guidelines, including treatment of patients with advanced disease, can be found online at the NCCN website.

Full Text

Duke Authors

Cited Authors

  • Mohler, JL; Kantoff, PW; Armstrong, AJ; Bahnson, RR; Cohen, M; D'Amico, AV; Eastham, JA; Enke, CA; Farrington, TA; Higano, CS; Horwitz, EM; Kane, CJ; Kawachi, MH; Kuettel, M; Kuzel, TM; Lee, RJ; Malcolm, AW; Miller, D; Plimack, ER; Pow-Sang, JM; Raben, D; Richey, S; Roach, M; Rohren, E; Rosenfeld, S; Schaeffer, E; Small, EJ; Sonpavde, G; Srinivas, S; Stein, C; Strope, SA; Tward, J; Shead, DA; Ho, M; National Comprehensive Cancer Network,

Published Date

  • May 2014

Published In

Volume / Issue

  • 12 / 5

Start / End Page

  • 686 - 718

PubMed ID

  • 24812137

Pubmed Central ID

  • 24812137

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2014.0072

Language

  • eng

Conference Location

  • United States